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Background and purpose: The benefit of reduced radiation heart exposure in the prone vs. supine position
individually differs. In this prospective cohort study, the goal was to develop a simple method for the
operation of a validated model for the prediction of preferable treatment position during left breast
radiotherapy.
Material and methods: In 100 cases, a single CT slice was utilized for the collection of the needed patient-
specific data (in addition to body mass index, the distance of the LAD from the chest wall and the area of
the heart included in the radiation fields at the middle of the heart in the supine position). Outcome was
analyzed in relation to the full CT series acquired in both positions and dosimetric data.
Results: Great consistency was found between the tested and original method regarding sensitivity and
specificity. The prioritization of LAD dose, and the use of heart dose and position-specific dose constraints
as safety measures ensure sensitivity and specificity values of 82.8% and 87.3%, respectively. In an addi-
tional ‘‘routine clinical practice” series of 60 patients the new method seemed feasible in routine clinical
practice. External testing on a 28-case series indicated similar accuracy.
Conclusion: We consider this simple clinical tool appropriate for assisting individual positioning aiming
at maximum heart protection during left breast irradiation.
 2018 Elsevier B.V. All rights reserved. Radiotherapy and Oncology 126 (2018) 487–492Radiotherapy is an essential component of the management of
early breast cancer. The outcome in most cases is favorable, the
majority of the affected patients become long survivors. Breast
radiotherapy, however, may increase the risk of non-breast
cancer-related morbidities, among which heart diseases rank the
first [1,2]. Radiation-induced heart damage clearly depends on
the dose exposed to its different structures (3,4). While older radio-
therapy practices caused more significant late hazards, heightened
awareness and the use of current technical developments make
this danger much lower [1,4,5]. Although the application of mod-
ern radiotherapy planning and delivery significantly improves
the control of radiation dose, in many cases a part of the heart,
and especially the left anterior descending artery (LAD) located
to its anterior surface still receive a dose sufficient to cause long-
term adverse effects. Radiogenic diffuse myocardium damage
including microvasculature abnormalities, degenerative cardiomy-
ocyte and interstitial fibrotic changes may be controlled if notextensive, but the damage of the macrovasculature indistinguish-
able from coronary arteriosclerosis due to other causes more likely
lead to a fatal outcome [3,6–8]. The exposure of the heart and the
LAD are related [9–11], and irradiation-related cardiac morbidity
and mortality are considered to be consequences of late manifest-
ing coronary artery damage. Hence the verification and control of
the dose to the LAD, is of prime importance [8,9,11,12].
With the aim of cardiac dose sparing and avoidance, numerous
newmethods have been developed [4,5]. These include the breath-
holding techniques, prone positioning (both operate by separating
the heart and the radiation fields), IMRT, proton irradiation or the
reduction in the volume to be irradiated, partial breast irradiation
(PBI). A significant increase in the number of clinical studies
[11–20], and a recent survey on clinical practice [21] suggest that
prone positioning has become an alternative of conventional
supine positioning in some centers. Prone positioning always pro-
vides dramatic reduction in the ipsilateral lung dose, and in many
cases significantly reduces heart exposure, too. A potential
disadvantage is inferior repositioning accuracy, which may be
improved with experience [18] or may be compensated by online
daily correction [12,22].
488 Predictive tool for positioningProne positioning was first invented for the irradiation of large-
breasted women [23,24]. Indeed, since gravity pulls the breast
away from the chest wall, the geometry of a pendulous breast
and the tangential irradiation fields gets advantageous in the prone
position [12]. Taking the overall population of breast cancer
patients, however, prone positioning has such effect in 77–87% of
cases only [11,14,15,19]. As a consequence, the position-
dependent dose to the LAD or heart also individually differs
[11,19,20]. Different approaches exist for selecting the optimal
position in left breast cancer cases. Kirby et al. found that a PTV
> 1000 cm3 favors prone positioning [11]. Zhao et al. developed a
two-step decision-analysis algorithm that, based on the anatomi-
cal features detected on a prone CT series, classified patients to
prone radiotherapy or to a second CT in the supine position for
comparison [25]. We have demonstrated that a statistical model
utilizing 3 anatomical determinants (the body mass index [BMI],
the distance of the LAD from the chest wall and the area of the
heart included in the radiation fields at the middle of the heart
in the supine position) of the patient gives accurate estimates on
the benefit of one specific position over the other by means of
LAD or heart doses [19]. Here we report on an original method
for providing the necessary patient-specific data based on a single
CT slice image representing the middle of the heart. In this
prospective study, following the validation of the clinical tool, also
its routine use has been tested on a separate series of cases.Patients and methods
The study was approved by the Institutional Review Board of
the University of Szeged, and all the enrolled patients gave their
written informed consent to participation. Eligible patients needed
postoperative left breast radiotherapy.Outline of the study
First, a single CT slice image at the middle of the heart (refer-
ence plane, Pref) was acquired with the help of an AP scout view
in the supine position (Fig. 1A). On that CT scan, the shortest dis-
tance between the anterior surface of the LAD and the chest wall
(Dmed) and the area of the heart (Aheart) included in the radiation
fields were measured after placing a straight line between the bor-
der of the ipsilateral latissimus dorsi muscle and the lateral edge of
the sternum (Fig. 1B); these data (representing the topography of
the heart) were introduced to the calculator together with the
patient’s BMI (which correlated with the volumes of the breast
and heart) as previously described in detail [19]. The calculator
based on a validated statistical model provided the estimated
LAD and heart dose differences in the prone vs. supine position
of the individual patient. In the first validation set of 100 patients,Fig. 1. The simple clinical tool generates patient-specific data to predict the benefit
of prone positioning. After selecting the reference plane (Pref) at the middle of the
heart on the AP scout view (A), a single CT slice is acquired for the measurement of
those determinants (Dmed and Aheart) (B) which operate the calculator to provide
estimates of the doses to the LAD or heart.CT series were acquired in both the supine position and prone posi-
tion. Conformal radiation treatment plans were generated in both
positions using conventional 6 MV tangential photon fields set up
isocentrically and median 2 (1–3) individually weighted 6/15 MV
segmental fields superimposed on the tangential fields using a
multileaf collimator as described [18,19]. Wedges were used in
almost all supine radiation plans. A mean dose to the PTV of 50
Gy (25 fractions) and a uniform distribution (5% + 7%) of the pre-
scribed dose to 95% of the PTV, were aimed at. The consistency of
all contouring activities had been ensured by a chief radiation
oncologist (ZK) and an experienced radiologist (AC) [26]. Equiva-
lent heart and LAD volume contouring in either setup was ensured
by one author (ZK). In the next ‘‘routine clinical practice” set of 60
patients, the acquisition of a single series of CT images according to
the suggestion of the calculator was aimed at, and a second CT ser-
ies was taken only if any of the dose constraints approved for the
specific position were not reached in the position suggested by
the calculator. In this series of patients’ dose constraints were spec-
ified on the basis of previously recorded data. The upper range lim-
its of the 90% percentile of dosimetry data in the preferred position
were the following: mean LAD dose [MDLAD]: 12.9 Gy and 12.5 Gy,
V25Gyheart: 2.4% and 4.7%, in the prone position and supine position,
respectively. In true discordant cases, our strategy for selecting
treatment position was to consider the LAD dose as a primary deci-
sive factor.
In the validation set, data on LAD and heart dose differences
between the two treatment positions were extracted from the
planning system and estimated by the calculator, whereas in the
‘‘routine clinical practice” series only the estimated dose
differences were available. Analyses were performed on 1. the
equivalence of the Pref with the median plane of the full series of
CT scans acquired in the supine position (Pmed) and 2. the effect
of plane miss on the patient-related determinants and choice of
preferable position. The sensitivity and specificity of this simple
clinical method were evaluated based on the dosimetry data
obtained using the topogram for selecting the position (n = 100).
In the ‘‘routine clinical practice” series, the acceptability of the
position as predicted by the calculator, the LAD and heart doses
achieved without taking 2 CT series, and the need of performing
a second CT series and changing position or irradiation technique
were analyzed.External testing
The supine and prone CT series and supine topogram of patients
included in the study ‘‘Individualized positioning for maximum
heart and index breast protection during breast irradiation: com-
parative study between Prone and Supine (Approval: 26/09/2013,
B707201318246) were retrospectively used for independent test-
ing. The protocol of patient positioning, delineation and radiation
treatment planning has been described [27].
First, Pref was selected on the topogram. Then, the predictors
BMI, Dmed, Aheart as measured in Pref were introduced to the calcu-
lator. As a second step, Dmed, Aheart were also measured in Pmed. LAD
and heart dose differences between the two treatment positions
extracted from the planning system and estimated by the calcula-
tor were analyzed. Finally, the correctness of Pref was evaluated.Statistical methods
The calculator had been developed based on linear regression
models utilizing the patients’ anatomical features, with DMDLAD
and DV25Gyheart as dependent variables [19]. With a single cut-off
point, a case was classified to prone positioning when the pre-
dicted value exceeded that value. Thresholds were optimized
based on sensitivity and specificity as calculated from previous
Table 1
Classification measures for DMDLAD and DV25Gyheart using a single discrimination threshold. Great consistency is seen between the original cohort [19] and the present series.
Original method (double CT method, n = 83) Simple tool (single CT method, n = 100)
Cut-off point Sensitivity (%) Specificity (%) Sensitivity (%) Specificity (%)
DMDLAD (Gy) 0.6 66.6 91.1 72.4 91.5
0.3 70.8 90.7 75.9 91.5
0 74.4 90.0 75.9 91.5
0.3 77.7 88.9 79.3 88.7
0.6 80.7 87.5 82.8 87.3
0.9 83.4 86.0 82.8 83.1
1.2 85.4 83.6 86.2 81.7
1.5 86.5 81.7 86.2 77.5
1.8 86.8 79.9 93.1 76.1
DV25Gyheart (%) 0 47.9 89.7 50 90.8
0.25 56.2 88.8 58.3 89.5
0.50 63.2 85.9 64 88
0.75 72.4 82.4 68 85.3
1 78.8 77.7 80 85.3
1.25 84.0 74.0 84 81.3
1.50 87.4 77.0 92 78.6
1.75 89.9 62.1 96 74.6
Table 2
Dmed and Aheart values (mean ± SD) as measured on Pref vs. Pmed in all cases or in correctly and incorrectly specified Pref cases; the measurements were performed on 2 CT scans at
the middle of the heart either identified with the help of an A-P scout view (Pref) or selected from a full CT series (Pmed).
All cases (n = 100) Correct plane (n = 55) Plane miss (n = 45)
Pref Pmed Pref Pmed Pref Pmed
Dmedian (cm) 1.27 ± 0.59 1.25 ± 0.67 1.35 ± 0.55 1.17 ± 0.63 1.18 ± 0.63 1.34 ± 0.71
Aheart (mm2) 768.8 ± 487.4 671.6 ± 450.1 730.7 ± 537.4 721.5 ± 511.2 815.4 ± 419.5 610.5 ± 358.1
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culated with supine positioning as positive determinant in the
model. For DMDLAD a threshold of 0.6 Gy, and for DV25Gyheart a
cut-off point of 1.0% were chosen. In the definition of the cut-off
points, a sensitivity of 80% at the minimum and the maximum
achievable value of specificity was required.
LAD and heart dose constraints achievable by selecting the
preferable position were specified by percentage estimation. Sta-
tistical analysis was performed with SPSS 22.0 for Windows.
Results
Validation set
In 55/100 cases, Pref was the same as Pmed while in 28 and 17
cases, Pref and Pmed differed by 1 or more planes, respectively. More
among the incorrectly defined Pref cases were shifted toward the
caudal than the cranial direction. This resulted in smaller mean
Dmed and larger mean Aheart values among the plane miss cases
overall (Table 2). Within the whole series, no change in the fre-
quency of plane misses could be detected by time. Incongruency
among DMDLAD and DV25Gyheart in the supine and prone position
as predicted by the calculator on the basis of Pref vs. Pmed data,
was present in 14 and 18 of the cases, respectively; these were
all of small numerical values (Fig. 2A, B). When the LAD and heart
dose differences predicted by the calculator based on the Pref val-
ues were compared with the original dosimetric data from plans
generated in both positions, the suggestion proved invalid in 14
(MDLAD) and 16 (V25Gyheart) cases (Fig. 2C, D). We have compared
the sensitivity and specificity of DMDLAD and DV25Gyheart provided
by the simple method based on a single CT scan with that of the
original method that indicated high consistency [19] (Table 1).
Based on these findings, the cut-off values of 0.6 Gy (DMDLAD)
and 1.0% (DV25Gyheart) have been selected for further analyses and
practice.Next, the concordance of calculator-predicted treatment posi-
tion based on DMDLAD vs. DV25Gyheart and the need for intervention
were analyzed in the validation set. In 28 supine-predicted cases
and 64 prone-predicted cases, the same treatment position was
suggested by both measures (Table 3). Among the 28 supine-
predicted cases in 2, the radiotherapy plan revealed that MDLAD
> 12.5 Gy, but only 1 could be improved by changing the treatment
position. Among the 64 prone-predicted cases in 8, the MDLAD
exceeded the dose constraint of 12.9 Gy; only 3 plans could be
improved by applying the supine position. Among the discordant
cases, DMDLAD suggested prone position in 3 and supine position
in 5 cases; in both groups in a single case each could the LAD dose
be improved by changing the treatment position. In altogether 7
cases, a different intervention (IMRT) had to be applied (Table 3).‘‘Routine clinical practice” set
In the ‘‘routine clinical practice” series of 60 patients, the new
method proved feasible. All patients received treatment in the
position suggested by the calculator except one, who had to receive
a second CT in the other position due to unacceptable LAD dose.
The other patients had MDLAD and V25Gyheart values well below
the predefined dose limits, and these were similar to the values
calculated in the validation set (Table 4).External testing
In a series of 28 breast cancer patients from Liege, the predictors
BMI, Dmed and Aheart significantly differed from the same parame-
ters among the patients from Szeged. In 18/28 cases, Pref was equal
or close to Pmed (6 mm), while in 10, cases Pref varied from Pmed by
9–16 mm. Comparing the calculator-provided dose differences
with the treatment planning data, favored treatment position
was correct in 24/28 (accuracy: 85.7%) and 23/28 (accuracy:
82.1%) cases taking into account the LAD and heart doses,
Fig. 2. Calculator suggestion of LAD (A) and heart (B) dose differences by the input of Dmed and Aheart based on Pref vs. Pmed; LAD (C) and heart (D) doses according to the
estimation of the simple clinical method based on a single CT scan vs. DVH data extracted from the planning system (n = 100). Dashed lines indicate the cut-off values of 0.6
Gy (DMDLAD) and 1.0% (DV25Gyheart) specified by sensitivity and specificity values.
Table 3
Concordance of treatment position as predicted by DMDLAD vs. DV25Gyheart, in the validation set (n = 100). In concordant cases the suggested position, in discordant cases the
position suggested by DMDLAD was applied unless the dose constraints were exceeded; in such cases the other treatment position or alternative techniques may be tested.
DV25Gyheart
Supine Prone
All MDLAD > 12.5 Gy Change position Other intervention All MDLAD > 12.9 Gy Change position Other intervention
DMDLAD Supine 28 2 1/2 1/2 5 1/5 1/1 –
Prone 3 2/3 1/2 1/2 64 8/64 3/8 5/8
Table 4
LAD and heart doses in the validation set and the ‘‘routine clinical practice” series: in the majority of cases, LAD and heart doses were well below the position-related dose
constraints; for those patients who had higher than accepted doses, an alternative technique had to be applied.
Treatment position n (%) Mean LAD dose (Gy) V25Gyheart (%)
Mean SD Min Max Mean SD Min Max
Validation series Prone 67 (67.0) 6.55 6.03 1.70 26.66 1.16 2.24 0.0 8.75
Supine 33 (33.0) 6.90 3.86 1.71 13.73 1.54 1.38 0.0 4.77
‘‘Routine clinical practice‘‘ series Prone 47 (78.3) 6.58 2.29 1.95 11.24 0.86 0.57 0.1 2.67
Supine 13 (21.7) 7.35 3.05 2.54 15.85 1.15 0.95 0.21 3.57
490 Predictive tool for positioningrespectively. Sensitivity and specificity of DMDLAD was 83.3% and
86.4%, respectively, whereas sensitivity and specificity of
DV25Gyheart was 100.0% and 80.0%, respectively.Discussion
According to the present study and others [11,14,15,19,20], in
about 20% of the cases, prone positioning during left breast radio-therapy increases the dose to the LAD or the heart. To estimate and
select the preferable positioning mode, supine CT seems the best
approach to consider the patient’s anatomical determinants. We
have shown that a single CT scan at the middle of the heart may
replace a whole CT series by providing consistent anatomical data
thus avoiding extra radiation exposure to the patient and work
load to the staff. Based on the outcome of the external implemen-
tation of the method on an independent case series, we recom-
mend its use after local testing.
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treatment position utilizes 3 specific measures, and seems the
most complex predictive tool for this purpose in the literature
[19]. In other studies, the in-field heart volume [16,17,25] and
most frequently the size of the breast [4,11] have been used for
selection. An increased BMI has also been related to larger heart
doses [28] or consequential radiation cardiac morbidity [29], but
its role in predicting benefit of prone positioning may be refined
by the use of other patient-related parameters [19]. We consider
the BMI in our calculator as a stable parameter while there is
potential uncertainty in the specification of Pref or imprecision in
the actual measurement of Dmedian or Aheart on a given image. Nev-
ertheless, detailed analysis indicates that accidental imprecision
does not significantly influence final prediction (data not shown).
The dose constraints optimized by individual positioning provides
additional safety in practice. Despite the lack of full equivalence of
the data extracted from the original method vs. the new method,
the ultimate consistency still seems to qualify the developed ‘‘sim-
ple tool” for clinical application.
External use indicated similar accuracy as the originally devel-
oped method. Despite the reassuring results on an independent
series of patients in a radiotherapy center using a slightly different
protocol, the utility of the reported clinical tool could be compro-
mised by the diversity of practice in others. PTV contouring
depends on repositioning accuracy and the method of treatment
verification. Interfractional differences may be especially large in
the prone position [18,30]. Lakosi et al. found population system-
atic error values of 4.5/3.9/3.3 mm in the lateral/longitudinal/verti-
cal directions, while the random error was 5.4/3.8/2.8 mm [27].
Among our recent breast radiotherapy cases, the population sys-
tematic and random error in the lateral/longitudinal/vertical direc-
tions was similar in the prone position vs. supine position
(3.4/2.3/2.7 mm and 7.8/4.6/6.9 mm, respectively vs. 2.2/3.0/1.6
mm and 6.7/5.5/4.5 mm, respectively). Only some groups study
the dose to the coronary arteries [11,12,19,20,31–34]. The outlin-
ing of the coronary vessels shows significant inter-observer varia-
tion that may jeopardize dose verification in the selected position
[35,36]. Different approaches have been tested to improve consis-
tency including the administration of contrast media [35–37]. Lee
et al. developed a new protocol to outline the LAD region which
included 96% of the LAD volume as delineated by 4 experienced
radiation oncologists [37]. Significant impact was made by the
implementation of specific guidelines [35–37]. Since the utility of
the simple tool might be influenced by several factors, in addition
to the use of institutional LAD contouring guidelines and study of
inter-observer variation, we consider essential its testing before
routine use. In the case of hypofractionated radiotherapy, the
model parameters of the calculator should be re-estimated and
the dose constraints should be re-defined.
The benefit of positioning prone vs. supine may be discordant
by means of LAD and heart doses [11,19,34]. We regard the LAD
dose as a surrogate indicator of radiation harm due to its proven
role in late cardiac morbidity [3] and because the LAD being situ-
ated on the anterior surface of the heart is a sensitive marker of
danger if the heart is at all included into radiation. Our strategy
for optimization in individual cases is to consider the MDLAD as pri-
ority that is usually confirmed by the heart dose (as was true for
92% of cases in our series).
The radiation exposure of the heart may be significantly
reduced by the use of respiration-guided techniques including
the deep inspiration breath hold (DIBH) technique and respiratory
gating. In the UK HeartSpare study, supine DIBH provided superior
cardiac sparing than a free-breathing prone position in large-
breasted women [12]. Interestingly, the implementation of DIBH
in the prone position gave the optimal heart sparing results as
compared with that in the supine position or free-breathing [33].There are some centers that due to resource limitations prioritize
high cardiac dose cases for DIBH [38]. Our tool could be used for
patients either not amenable for or not having access to DIBH
due to patient-specific features (cardiorespiratory problems, lack
of compliance) or limited/no resources, respectively.
We think that since a linear, no-threshold association exists
between the mean heart dose and coronary events [3], doses to
the LAD, right coronary artery or the circumflex artery should be
controlled [20]. Nevertheless, the utilization of heart dose–volume
data only is a possibility if LAD contouring cannot be afforded.
Since good agreement exists between the mean heart dose and
V25Gyheart (Rprone: 0.98, Rsupine: 0.99) or MDLAD (Rprone and Rsu-
pine: 0.87) in both positions (p < 0.001 in all comparisons), here
the presented tool could be adapted to practices which adhere to
the consideration of the mean heart dose.
In summary, we have demonstrated great consistency of our
method based on a validated model for the prediction of treatment
position prone vs. supine with less heart exposure during left
breast radiotherapy; the simplified tool presented here omits the
performance of planning CT in both positions. Based on the results
of its external testing, we truly recommend its use in centers that
apply prone positioning in routine clinical practice. Due to differ-
ences in populations and radiotherapy protocols, local testing is
essential.Conclusion
We consider this simple clinical tool useful for assisting individ-
ual positioning in routine clinical practice aiming at maximum
heart protection during left breast irradiation.Conflict of interest
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